In recent months, H.I.G. Capital has demonstrated a strong commitment to expanding its influence in the healthcare sector through a series of strategic acquisitions. With $65 billion under management, the Miami-based investment firm is keen on identifying growth opportunities in both healthcare and related industries.
One of the most notable acquisitions by H.I.G. Capital is SkinCure Oncology. The company, which specializes in image-guided superficial radiation therapy, provides non-invasive treatment solutions for nonmelanoma skin cancer. This acquisition aligns with H.I.G.’s strategy to invest in innovative healthcare technologies that offer effective patient outcomes.
Beyond healthcare, H.I.G. Capital’s portfolio is diversifying into adjacent markets. The acquisition of Action Elevator marks the firm’s entry into services that support healthcare infrastructure. Action Elevator, known for its maintenance and modernization services, caters to clients across various sectors, including healthcare facilities, ensuring optimal operation of crucial building systems.
In addition to expanding its reach, H.I.G. Capital has also refined its portfolio through strategic divestitures. The sale of BIOVECTRA to Agilent Technologies for $925 million is a testament to its savvy investment strategy. Under H.I.G.’s ownership, BIOVECTRA grew significantly, benefiting from expanded capabilities in pharmaceutical manufacturing.
Moreover, H.I.G. Capital’s investment in Naturalia Tantum reflects its interest in the burgeoning natural and organic products market. Based in Italy, Naturalia Tantum is a leading developer of organic personal care products, a sector witnessing rapid growth as consumers increasingly prioritize natural ingredients.
These strategic moves underscore H.I.G. Capital’s adeptness at navigating complex investment landscapes. By diversifying its portfolio across healthcare and adjacent sectors, the firm is well-positioned to leverage future market trends and foster sustained growth.